Direct reprogramming of fibroblasts to myocytes via bacterial injection of MyoD protein

Cellular Reprogramming

Volumn 15, Issue 2, 2013, Pages 117-125

  Bichsel, Candace ^a   Neeld, Dennis ^a   Hamazaki, Takashi ^a   Chang, Lung Ji ^a   Yang, Li Jun ^a   Terada, Naohiro ^a   Jin, Shouguang ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MYOD PROTEIN; PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FATE; CELL TRANSDIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; EMBRYO; EUKARYOTIC CELL; FIBROBLAST; GENE EXPRESSION; MORPHOLOGY; MOUSE; MUSCLE CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TYPE III SECRETION SYSTEM;

ANIMALS; BACTERIAL SECRETION SYSTEMS; CELL LINE; CELL TRANSDIFFERENTIATION; FIBROBLASTS; HUMANS; MICE; MUSCLE CELLS; MYOD PROTEIN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TRANSDUCTION, GENETIC;

BACTERIA (MICROORGANISMS); EUKARYOTA; PSEUDOMONAS AERUGINOSA;

EID: 84875953308     PISSN: 21524971     EISSN: 21524998     Source Type: Journal    
DOI: 10.1089/cell.2012.0058     Document Type: Article

References (28)

1. Batonnet-Pichon, S., Tintignac, L.J., Castro, A., Sirri, V., Leibo-vitch, M.P., Lorca, T., and Leibovitch, S.A. (2006). MyoD undergoes a distinct G2/M-specific regulation in muscle cells. Exp. Cell Res. 312, 3999-4010.
2. Bichsel, C., Neeld, D.K., Hamazaki, T., Wu, D., Chang, L.J., Yang, L., Terada, N., and Jin, S. (2011). Bacterial delivery of nuclear proteins into pluripotent and differentiated cells. PLoS One 6, e16465.
3. Chambers, S.M., and Studer, L. (2011). Cell fate plug and play: Direct reprogramming and induced pluripotency. Cell 145, 827-830.
4. Cherry, A.B., and Daley, G.Q. (2012). Reprogramming cellular identity for regenerative medicine. Cell 148, 1110-1122.
5. Coburn, B., Sekirov, I., and Finlay, B.B. (2007). Type III secretion systems and disease. Clin. Microbiol. Rev. 20, 535-549.
6. Cornelis, G.R. (2006). The type III secretion injectisome. Nat. Rev. Microbiol. 4, 811-825.
7. Di Padova, M., Caretti, G., Zhao, P., Hoffman, E.P., and Sar-torelli, V. (2007). MyoD acetylation influences temporal patterns of skeletal muscle gene expression. J. Biol. Chem. 282, 37650-37659.
8. Hauser, A.R. (2009). The type III secretion system of Pseudomonas aeruginosa: Infection by injection. Nat. Rev. Microbiol. 7, 654-665.
9. Hayes, C.S., Aoki, S.K., and Low, D.A. (2010). Bacterial contact-dependent delivery systems. Annu. Genet. 44, 71-90.
10. Jo, C., Cho, S.J., and Jo, S.A. (2011). Mitogen-activated protein kinase kinase 1 (MEK1) stabilizes MyoD through direct phosphorylation at tyrosine 156 during myogenic differentiation. J. Biol. Chem. 286, 18903-18913.
11. Kitzmann, M., and Fernandez, A. (2001). Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts. Cell. Mol. Life Sci. 58, 571-579.
12. Ling, B.M., Bharathy, N., Chung, T.K., Kok, W.K., Li, S., Tan, Y.H., Rao, V.K., Gopinadhan, S., Sartorelli, V., Walsh, M.J., and Taneja, R. (2012). Lysine methyltransferase G9a methyl-ates the transcription factor MyoD and regulates skeletal muscle differentiation. Proc. Natl. Acad. Sci. USA 109, 841-846.
13. Lyons, A.B. (2000). Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243, 147-154.
14. Polesskaya, A., and Rudnicki, M.A. (2002). A MyoD-dependent differentiation checkpoint: Ensuring genome integrity. Dev. Cell 3, 757-758.
15. Sadeh, R., Breitschopf, K., Bercovich, B., Zoabi, M., Kravtsova-Ivantsiv, Y., Kornitzer, D., Schwartz, A., and Ciechanover, A. (2008). The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization- dependent degradation by the ubiquitin system. Proc. Natl. Acad. Sci. USA 105, 15690-15695.
16. Schoehn, G., Di Guilmi, A.M., Lemaire, D., Attree, I., Weissen-horn, W., and Dessen, A. (2003). Oligomerization of type III secretion proteins PopB and PopD precedes pore formation in Pseudomonas. EMBO J. 22, 4957-4967.
17. Tapscott, S.J. (2005). The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 132, 2685-2695.
18. Tapscott, S.J., Davis, R.L., Thayer, M.J., Cheng, P.F., Weintraub, H., and Lassar, A.B. (1988). MyoD1: A nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 242, 405-411.
19. Tintignac, L.A., Sirri, V., Leibovitch, M.P., Lecluse, Y., Castedo, M., Metivier, D., Kroemer, G., and Leibovitch, S.A. (2004). Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry. Mol. Cell. Biol. 24, 1809-1821.
20. Wagers, A.J., and Conboy, I.M. (2005). Cellular and molecular signatures of muscle regeneration: Current concepts and controversies in adult myogenesis. Cell 122, 659-667.
21. Wei, Q., and Paterson, B.M. (2001). Regulation of MyoD function in the dividing myoblast. FEBS Lett. 490, 171-178.
22. Weintraub, H., Tapscott, S.J., Davis, R.L., Thayer, M.J., Adam, M.A., Lassar, A.B., and Miller, A.D. (1989). Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibro-blast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. USA 86, 5434-5438.
23. West, S.E., Schweizer, H.P., Dall, C., Sample, A.K., and Runyen-Janecky, L.J. (1994). Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseu-domonas aeruginosa. Gene 148, 81-86.
24. Yahr, T.L., and Wolfgang, M.C. (2006). Transcriptional regulation of the Pseudomonas aeruginosa type III secretion system. Mol. Microbiol. 62, 631.
25. Yamanaka, S., and Blau, H.M. (2010). Nuclear reprogram-ming to a pluripotent state by three approaches. Nature 465, 704-712.
26. Yokoyama, S., and Asahara, H. (2011). The myogenic tran-scriptional network. Cell. Mol. Life Sci. 68, 1843-1849.
27. Yu, J., Rossi, R., Hale, C., Goulding, D., and Dougan, G. (2009). Interaction of enteric bacterial pathogens with murine embryonic stem cells. Infect. Immun. 77, 585-597.
28. Zaiss, A.K., Son, S., and Chang, L.J. (2002). RNA 3¢ readthrough of oncoretrovirus and lentivirus: Implications for vector safety and efficacy. J. Virol. 76, 7209-7219.